Antibiotic Resistance among Gram Negative Bacilli Isolated from the ICU Admitted Patients Attending Chitwan Medical College Teaching Hospital

S. Koju, N. Chaudhary, S. Adhikari, K. Adhikari
{"title":"Antibiotic Resistance among Gram Negative Bacilli Isolated from the ICU Admitted Patients Attending Chitwan Medical College Teaching Hospital","authors":"S. Koju, N. Chaudhary, S. Adhikari, K. Adhikari","doi":"10.3126/mjmms.v2i3.47748","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: Antimicrobial therapy is the main stone in treatment. Gram negative bacilli are common cause of sepsis, pneumonia and urinary tract infections in ICU patients. Their treatment becomes more challenging due to the evolution of multiple drug resistant strains. The findings of this study would be useful in the formation of effective diagnostic approaches and policy of antimicrobial therapy for the treatment of infections in a similar intensive care hospital setting.\nMATERIALS AND METHODS: A Laboratory based descriptive cross-sectional study was conducted at the department of clinical microbiology of the Chitwan Medical College Teaching Hospital based on the reports of 129 bacterial isolated of various clinical specimens from different ICUs of hospital between April 2018 to September 2018.\nRESULTS: Among the 129-gram bacilli isolated mono bacterial growth were 116(89.92%) while remaining 13(10.08%) had poly bacterial or mixed organisms isolated. The most frequently isolated organisms were Acinetobacter spp. 51(39.55%), Escherichia coli 25(19.37%), Klebsiella spp. 27(20.93%), Pseudomonas aeruginosa 17(13.95%) and Enterobacter spp. 8(6.2%). Antibiotic resistance was observed in many organisms with multidrug resistance 97(75.2%) among them. High level of resistance was observed to Cefotaxime (98.04%), Ceftriaxone (96.08%), Imipenem (80.39%), Ampicillin/sulbactam (72.55%) and Amikacin (70.59%). Ciprofloxacin (68.63%), Levofloxacin (27.45%) and Meropenem (28.21%) were found to be relatively effective against Acinetobacter spp. Isolated.\nCONCLUSIONS: Most of the frequently isolated organisms are multi drug resistant.  ","PeriodicalId":218847,"journal":{"name":"MedS Alliance Journal of Medicine and Medical Sciences","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedS Alliance Journal of Medicine and Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/mjmms.v2i3.47748","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION: Antimicrobial therapy is the main stone in treatment. Gram negative bacilli are common cause of sepsis, pneumonia and urinary tract infections in ICU patients. Their treatment becomes more challenging due to the evolution of multiple drug resistant strains. The findings of this study would be useful in the formation of effective diagnostic approaches and policy of antimicrobial therapy for the treatment of infections in a similar intensive care hospital setting. MATERIALS AND METHODS: A Laboratory based descriptive cross-sectional study was conducted at the department of clinical microbiology of the Chitwan Medical College Teaching Hospital based on the reports of 129 bacterial isolated of various clinical specimens from different ICUs of hospital between April 2018 to September 2018. RESULTS: Among the 129-gram bacilli isolated mono bacterial growth were 116(89.92%) while remaining 13(10.08%) had poly bacterial or mixed organisms isolated. The most frequently isolated organisms were Acinetobacter spp. 51(39.55%), Escherichia coli 25(19.37%), Klebsiella spp. 27(20.93%), Pseudomonas aeruginosa 17(13.95%) and Enterobacter spp. 8(6.2%). Antibiotic resistance was observed in many organisms with multidrug resistance 97(75.2%) among them. High level of resistance was observed to Cefotaxime (98.04%), Ceftriaxone (96.08%), Imipenem (80.39%), Ampicillin/sulbactam (72.55%) and Amikacin (70.59%). Ciprofloxacin (68.63%), Levofloxacin (27.45%) and Meropenem (28.21%) were found to be relatively effective against Acinetobacter spp. Isolated. CONCLUSIONS: Most of the frequently isolated organisms are multi drug resistant.  
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
奇旺医学院附属医院ICU住院患者革兰氏阴性杆菌耐药性分析
简介:抗菌治疗是治疗的主要手段。革兰氏阴性杆菌是ICU患者脓毒症、肺炎和尿路感染的常见病因。由于多种耐药菌株的进化,它们的治疗变得更具挑战性。本研究结果将有助于在类似的重症监护医院环境中形成有效的诊断方法和抗菌治疗政策。材料与方法:根据2018年4月至2018年9月在Chitwan医学院教学医院临床微生物科从不同icu的临床标本中分离出的129株细菌的报告,在实验室基础上进行描述性横断面研究。结果:分离的129克杆菌中,单菌116株(89.92%),多菌或混合菌13株(10.08%);最常见的分离菌为不动杆菌51(39.55%)、大肠杆菌25(19.37%)、克雷伯氏菌27(20.93%)、铜绿假单胞菌17(13.95%)和肠杆菌8(6.2%)。多种细菌均出现耐药性,其中多药耐药97例(75.2%)。对头孢噻肟(98.04%)、头孢曲松(96.08%)、亚胺培南(80.39%)、氨苄西林/舒巴坦(72.55%)、阿米卡星(70.59%)耐药程度较高。环丙沙星(68.63%)、左氧氟沙星(27.45%)和美罗培南(28.21%)对分离的不动杆菌有较好的抗菌效果。结论:常见分离出的细菌多为多重耐药菌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Trends of Populations indicators in developed and developing countries: A Comparative Study Evaluation of Blood Group in Co-relation with the Dermatoglyphics Patterns among Medical Students: A Cross-Sectional Study Formulation Optimization and in-vitro Evaluation of Diclofenac Fast Disintegrating Tablets Health Related Quality of Life of Patients with Cardiovascular Disease attending Sahid Ganagalal National Heart Center, Janakpurdham, Province 2, Nepal Drug Utilization Pattern in Pneumonia among Pediatric Patients at a Tertiary Care Hospital
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1